Clinical Trial Update: Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating a comparison between berberine and metformin for metabolic syndrome in schizophrenia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Schizophrenia

Drugs mentioned

• Berberine (berberine)
• metformin (metformin)

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia, Metabolic Syndrome | Phase 4 | Status: UNKNOWN